- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01938066
Procellera and Negative Pressure Therapy for Acute Wounds
March 21, 2016 updated by: Gayle Gordillo
Clinical Outcomes for Patients With Acute Surgical Wounds Treated With Procellera and Negative Pressure Therapy Versus Standard of Care, Negative Pressure Therapy Only
The purpose of this study is to determine if Procellera speeds wound healing.
The study will examine colonization (bacterial growth), pain and pain medication and reduced cost of care by using Procellera (an antimicrobial agent) under Negative Pressure Therapy placed on the wound after abdominal wall surgery.
Procellera is a single layer dressing that helps to kill germs that cause infections.
Negative Pressure Therapy is a vacuum device with a sponge that is placed in your wound to help heal the wound faster.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will consent 30 patients undergoing surgery through the abdominal wall and the skin incision will intentionally be left open.
Subjects will be randomized using a random number generator.
Each number will be placed in an envelope numbered 1-30.
Arm 1 will be even numbers and Arm 2 will be odd numbers.
A researcher not affiliated with the study will generate the numbers and place them in the envelopes.
Arm 1 will place fifteen subjects on Negative Pressure Therapy Only and Arm 2 will place fifteen subjects on Negative Pressure and Procellera.
Arm 1 (Negative Pressure Only) will have their dressing changed 3 times per week which is the standard of care for Negative Pressure Therapy.
Arm 2 (Negative Pressure Therapy and Procellera) will have their dressing changed every 5 days.
Arm 1 and 2 will have a tissue specimen taken on the 5th day only.
The tissue will be taken from debrided material and sent for culture.
The Negative Pressure Therapy Sponge, which is discarded after each dressing change, will be collected, lavaged with saline and the cells will be examined for macrophage function and the wound fluid will be tested for inflammation response.
Photographs, wound measurements, pain scale and pain medication will also be completed at each dressing change.
We will check the progress of the wound along with your surgeon during the subject's 30 day surgical follow up in the surgeon's office.
The wound will be measured (if not healed), photograph's taken and their pain level assessed.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- University Hosptial East
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years old that are undergoing abdominal wall surgery
Exclusion Criteria:
- Below 18 years old and not having abdominal wall surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Negative Pressure with Procellera
Arm 2 is Negative Pressure Therapy and Procellera Dressing under the sponge dressing of the Negative Pressure Therapy.
The dressing will be changed at the end of 5 days.
This is the intervention arm of the study.
|
bioelectric wound dressing
|
|
SHAM_COMPARATOR: Negative Pressure Therapy only
Arm 1 is Negative Pressure Therapy only with no Procellera Dressing and the dressing is changed every other day per standard of care when you use Negative Pressure Therapy with no dressing underneath the sponge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound Infection
Time Frame: At the end of 5 days
|
At the end of 5 days all subjects will get a Culture and Sensitivity to see if they have an infection or what type of infection they have in the wound
|
At the end of 5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of Pain Medication Used (Morphine)
Time Frame: 5 days
|
will measure the amount of pain medication used (morphine)
|
5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
December 1, 2014
Study Registration Dates
First Submitted
September 4, 2013
First Submitted That Met QC Criteria
September 4, 2013
First Posted (ESTIMATE)
September 10, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
April 21, 2016
Last Update Submitted That Met QC Criteria
March 21, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013H0028
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound
-
Brigham and Women's HospitalCompletedSurgical Wound | Wound Heal | Wound of Skin | Wound OpenUnited States
-
ConvaTec Inc.WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Chandan SenUniversity of Colorado, DenverRecruitingInfections | Wound Infection | Wound Heal | Wound of Skin | Wound Healing DelayedUkraine
-
Massachusetts General HospitalCompletedWound Healing | Traumatic Wound | Infective Wound | Iatrogenic Critical Sized Wound DefectsUnited States
-
Indus Hospital and Health NetworkCompletedWound Closure After Total Knee Arthroplasty: Comparison of Polypropylene and Polyglactin 910 Suture.Wound Heal | Wound Complication | Wound DehiscencePakistan
-
Brigham and Women's HospitalRecruitingWound Infection and Wound HealingUnited States
-
khalid abd aziz mohamedArmed Forces Hospitals, Southern Region, Saudi ArabiaUnknownDecreasing Wound InfectionSaudi Arabia
-
Central Finland Hospital DistrictUniversity of Eastern Finland; Tampere University HospitalActive, not recruitingWound Heal | Wound | Skin Wound | Skin Scarring | Wound of Skin | Wound Open | Wound BreakdownFinland
-
Pulmatrix Inc.TerminatedPost Operative Wound Infection | Postoperative Wound Infection-deepUnited States
-
University of Roma La SapienzaCompletedWound Heal | Wound Surgical | Oral Soft Tissue ConditionsItaly
Clinical Trials on Procellera
-
Vomaris InnovationsCompletedBurns | Wound HealingUnited States
-
Gayle GordilloNationwide Children's HospitalWithdrawn
-
The Metis FoundationIndiana UniversityCompletedTrauma-related Wound | Burn, Partial ThicknessUnited States
-
Henry M. Jackson Foundation for the Advancement...TerminatedNon-healing Soft Tissue WoundsUnited States
-
Vomaris InnovationsCompleted
-
Vomaris InnovationsCompletedWound Infection | Wound HealingUnited States
-
Vomaris InnovationsCompleted
-
Indiana UniversityUnited States Department of Defense; Naval Medical Research CenterCompletedWound HealUnited States